Abstract
Seven phenolic compounds including p-coumaric acid (1), 4-hydroxybenzoic acid (2), 4-hydroxy-benzaldehyde (3), vanillic acid (4), luteolin (5), acacetin (6), and tricin (7), were isolated from the methylene chloride and ethyl acetate fractions of Echinochloa utilis grains. Compounds (1–4, 6) were isolated for the first time from this plant. These compounds were tested for inhibitory activities against LPS-induced NO production in RAW 264.7 cells. Compounds 5 and 6 displayed significant inhibitory effects, with IC50 values of 27.9 ± 2.6 and 14.0 ± 1.1 µM, respectively. The results suggested that E. utilis ethanolic extract may be used as a potential source of anti-inflammatory agents and functional foods for the treatment of allergic diseases.
REFERENCES
(1). Zedler S., Faist E.Curr. Opin. Crit. Care. 2006; 12:595–601.
(2). Mariathasan S., Monack D. M.Nat. Rev. Immunol. 2007; 7:31–40.
(3). Korhonen R., Lahti A., Kankaanranta H., Moilanen E.Curr. Drug Targets Inflamm. Allergy. 2005; 4:471–479.
(4). Salvemini D., Ischiropoulos H., Cuzzocrea S.Methods Mol. Biol. 2003; 225:291–303.
(5). Yabuno T.Econ. Bot. 1987; 41:484–493.
(6). Nozawa S., Takahashi M., Nakai H., Sato Y.Breed. Sci. 2006; 56:335–340.
(7). Park K.Y., Park R. K., Choi B. H.Korean J. Crop Sci. 1991; 36:249–253.
(8). Kim J. Y., Jang K. C., Park B. R., Han S. I., Choi K. J., Kim S. Y., Oh S. H., Ra J. E., Ha T. J., Lee J. H., Hwang J. Y., Kang H. W., Seo W. D.Food Sci. Biotechnol. 2011; 20:461–469.
(9). Watanabe M. J.Agric. Food Chem. 1999; 47:4500–4505.
(10). Migliorini P., Corradin G., Corradin S. B. J.Immunol. Methods. 1991; 139:107–114.
(11). Lee Y. J., Han J. Y., Lee C. G., Heo K., Park S. I., Park Y. S., Kim J. S., Yang K. M., Lee K. J., Kim T. H., Rhee M. H., Kim S. D. J.Ginseng Res. 2014; 38:208–214.
(12). Yang J., Wang D., Liu W., Zhang X., Bian F., Yu W.Green Chem. 2013; 15:3429–3437.
(13). Yayli N., Yildirim N., Usta A., Özkurt S., Akgün V., Turk J.Chem. 2003; 27:749–756.
(14). Xu M. L., Wang L., Hu J. H., Wang M. H. J.Food Sci. Nutr. 2009; 14:354–357.
(15). Chang S. W., Kim K. H., Lee I. K., Choi S. U., Ryu S. Y., Lee K. R.Nat. Prod. Sci. 2009; 15:234–240.
(16). Wagner H., Chari V. M., Sonnenbichler J.Tetrahedron Lett. 1976; 17:1799–1802.
(17). Shimoi K., Masuda S., Furugori M., Esaki S., Kinae N.Carcinogenesis. 1994; 15:2669–2672.
(18). Yamamoto H., Sakakibara J., Nagatsu A., Sekiya K. J.Agric. Food Chem. 1998; 46:862–865.
(19). Lin Y., Shi R., Wang X., Shen H. M.Curr. Cancer Drug Targets. 2008; 8:634–646.
(20). Seelinger G., Merfort I., Schempp C. M.Planta Med. 2008; 74:1667–1677.
(21). Park C. M., Song Y. S.Nutr. Res. Pract. 2013; 7:423–429.
(22). Yang Z. G., Jia L. N., Shen Y., Ohmura A., Kitanaka S.Molecules. 2011; 16:8305–8318.
(23). Chan T. S., Galati G., Pannala A. S., Rice-Evans C., O'Brien P. J.Free Radic. Res. 2003; 37:787–794.
(24). Pan M. H., Lai C. S., Wang Y. J., Ho C. T.Biochem. Pharmacol. 2006; 72:1293–1303.
(25). Srisook K., Srisook E., Nachaiyo W., Chan-In M., Thongbai J., Wongyoo K., Chawsuanthong S., Wannasri K., Intasuwan S., Watcharanawee K. J.Ethnopharmacol. 2015; 165:94–102.
Table 1.
Compounds | NO production and cell viabilityb | |
---|---|---|
IC50 value (µM) | Survival rate (%) | |
1 | > 100 | > 99 |
2 | > 100 | > 99 |
3 | > 100 | > 99 |
4 | > 100 | 100 |
5 | 27.9 ± 2.6 | > 99 |
6 | 14.0 ± 1.1 | 100 |
7 | > 100 | > 99 |
Dexamethasonea | 0.4 ± 0.05 | 100 |